Murray Stahl’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Hold
15,350
0.01% 188
2026
Q1
$564K Hold
15,350
0.01% 214
2025
Q4
$781K Hold
15,350
0.01% 186
2025
Q3
$852K Sell
15,350
-248
-2% -$14.5K 0.01% 185
2025
Q2
$1.08M Sell
15,598
-118
-0.8% -$8.03K 0.01% 173
2025
Q1
$1.09M Hold
15,716
0.01% 170
2024
Q4
$1.35M Sell
15,716
-2
-0% -$216 0.02% 150
2024
Q3
$1.87M Buy
15,718
+250
+2% +$33.3K 0.03% 128
2024
Q2
$2.21M Hold
15,468
0.04% 94
2024
Q1
$1.99M Sell
15,468
-12
-0.1% -$1.43K 0.04% 103
2023
Q4
$1.6M Hold
15,480
0.03% 114
2023
Q3
$1.41M Hold
15,480
0.03% 121
2023
Q2
$1.25M Hold
15,480
0.03% 136
2023
Q1
$1.23M Hold
15,480
0.02% 135
2022
Q4
$1.05M Hold
15,480
0.02% 149
2022
Q3
$771K Hold
15,480
0.02% 169
2022
Q2
$862K Hold
15,480
0.02% 170
2022
Q1
$860K Hold
15,480
0.02% 189
2021
Q4
$867K Hold
15,480
0.02% 193
2021
Q3
$743K Hold
15,480
0.02% 207
2021
Q2
$648K Hold
15,480
0.01% 218
2021
Q1
$522K Hold
15,480
0.01% 239
2020
Q4
$541K Hold
15,480
0.02% 230
2020
Q3
$537K Hold
15,480
0.02% 236
2020
Q2
$507K Hold
15,480
0.02% 237
2020
Q1
$466K Hold
15,480
0.02% 221
2019
Q4
$448K Hold
15,480
0.01% 258
2019
Q3
$400K Hold
15,480
0.01% 279
2019
Q2
$395K Hold
15,480
0.01% 286
2019
Q1
$405K Buy
+15,480
New +$380K 0.01% 280

Other funds holding NVO

Murray Stahl's NVO Position: Q2 2026 in Review

Murray Stahl held its Novo Nordisk (NVO) position steady in Q2 2026 at 15,350 shares worth $736K. The position accounts for 0.01% of the portfolio, ranked #188.

Murray Stahl first reported a position in NVO in Q1 2019 and has held it in 30 quarters since. The position peaked at $2.21M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Murray Stahl held 15,350 shares of Novo Nordisk worth $736K as of Q2 2026.
  • Murray Stahl left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Murray Stahl's portfolio in Q2 2026, its #188 holding.
  • Murray Stahl first reported a position in Novo Nordisk in Q1 2019 and has held it in 30 quarters since.
  • Murray Stahl's Novo Nordisk position peaked at $2.21M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.